Lv1
70 积分 2024-04-28 加入
Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis
9天前
已完结
Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
9天前
已完结
Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma
10天前
已关闭
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
11天前
已完结
HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance
12天前
已完结
Synthesis, Crystal Structure, and Spectral Characterization of Flumatinib Mesylate
12天前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
27天前
已完结
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria
27天前
已完结
Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres
2个月前
已完结
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
2个月前
已完结
皖公网安备34019202002308
